LEADER 01243nam  2200421   450 
001 9910796793503321
005 20230817190546.0
010   $a1-68108-445-7
035   $a(CKB)4100000001301033
035   $a(MiAaPQ)EBC5695602
035   $a(EXLCZ)994100000001301033
100   $a20190302d2019      uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aFrontiers in clinical drug research$hVolume 4$iDiabetes and obesity /$fAtta-ur-Rahman
210  1$aSharjah, UAE :$cBentham Science Publishers,$d[2019]
210  4$dİ2019
215   $a1 online resource (280 pages)
225 0 $aFrontiers in Clinical Drug Research - Diabetes and Obesity,$x2467-9607 ;$vVolume 4
311   $a1-68108-446-5 
606   $aDiabetes
606   $aDiabetes$xTreatment
606   $aObesity
615  0$aDiabetes.
615  0$aDiabetes$xTreatment.
615  0$aObesity.
676   $a616.462
700   $aRahman$b Atta-ur-$f1942-$0544456
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910796793503321
996   $aFrontiers in clinical drug research$93686114
997   $aUNINA